CSG® (NASDAQ: CSGS) today announced that its Board of Directors approved the Company’s quarterly cash dividend payment of $0.28 per share of common stock to be paid on December 22, 2023 for shareho...
DENVER: CSG® (NASDAQ: CSGS) today announced that its Board of Directors approved the Company’s quarterly cash dividend payment of $0.28 per share of common stock to be paid on December 22, 2023 for shareholders of record as of the close of business on December 13, 2023.
About CSG
CSG empowers companies to build unforgettable experiences, making it easier for people and businesses to connect with, use and pay for the services they value most. Our customer experience, billing and payments solutions help companies of any size make money and make a difference. With our SaaS solutions, company leaders can take control of their future and tap into guidance along the way from our fiercely committed and forward-thinking CSGers around the world.
Want to be future-ready and a change-maker like the global brands that trust CSG? Visit csgi.com to learn more.
Contacts John Rea
Investor Relations
+1 (210) 687-4409
john.rea@csgi.com
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Resecurity, a U.S.-based leader in cyber threat intelligence and risk management solutions, is proud to announce its participation in DSEI Japan 2025,…
Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of Elarasys Worldwide,…
BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced that six abstracts have been accepted at the 2025 ASCO…
LICT Corporation (“LICT” or the “Company”; OTC Pink®: LICT) reports financial results for the quarter ended March 31, 2025. Total revenues for the first…